Diamyd´s subscription warrant provides SEK 28 million cash injection
Diamyd Medical reports today that the subscription of new shares upon exercise of the subscription warrant DIAM TO2B brought in SEK 28 million in cash injection.– We appreciate the continued support from our shareholders and warrant owners. Diamyd has made good progress during the year and this together with a large international interest for the Company, has made it possible to exercise the subscription warrants at the exercise price, says Elisabeth Lindner, President and CEO of Diamyd Medical. In May 2008 Diamyd Medical issued a direct emission of shares, where each share was followed by